The global surgical dressing market size was estimated at USD 3.4 billion in 2016 which is anticipated to grow at a CAGR of more than 5.6% during the forecast period. The number of organ transplant procedures worldwide was reported to be 126,670 and 17,945 in 2015 and 2000 respectively, according to the Global Observatory on Donations and Transplantation (GODT) database. This increase in the number of surgeries may be attributed to widespread awareness, supportive government policies, and advancement in technology with respect to surgeries.
U.S. surgical dressing market, by product, 2014 - 2025 (USD Billions)
Developed countries such as the U.S., the UK have well equipped Ambulatory Surgery Centers (ASC), where surgical procedures are conducted at a more economical rate and the patients may not have to stay overnight. The range and number of ASC are increasing in developed and developing countries, which is adding to the number of surgical procedures conducted worldwide, thus, a spike in the demand for these products is expected during the forecast period. Additionally, due to supportive insurance policies for surgical procedures conducted in ASC are covered and hence it may act as a driver for the industry.
Lifestyle disorders include diseases such as cardiovascular diseases, diabetes, chronic obstructive pulmonary disease obesity, metabolic syndrome, and some types of cancer. One of the major contributors to the market is cardiovascular disease-related surgeries, which in turn may increase the number of surgical procedures, which further may increase the demand for these products. Additionally, the number of bariatric surgical procedures conducted due to the increasing disease prevalence of diabetes and obesity is also estimated to grow, which may act as a driver for this industry.
The surgical dressing market is segmented into three types on the basis of products. This segmentation includes primary, secondary, and other dressings. The others segment mainly includes alternative therapies for wound healing such as NPWT. The primary segment holds the largest share for the year 2016 with a share of more than 45.0%.
Film dressings are made from polyurethane sheets, which make them thin, flexible, and transparent. These products act as adhesives. It also provides a moist healing atmosphere to promote wound healing. This type of dressing is not used on exuding wounds, as the adhesive inhibits the film from sticking to the exuding part of the wound. Which protects the wound from mechanical trauma and bacterial infection.
Composite dressings which are the part of primary dressings are the multiple layered, waterproof products. This product normally has three layers, the bottom layer which is made up of semi or non-adherent material which allows water to permeate to the next layer but prevents it from sticking to the granulating tissue.
The others segment which includes NPWT is anticipated to gain substantial share during the forecast period as it is estimated to be growing with a CAGR of around 7.0%. NPWT is expected to gain a market share due to the advantages of the device such as rapid wound healing, increased patient compliance, and decreasing chances of infection in the patient.
This vertical is segmented into diabetes based surgeries, cardiovascular based surgeries, ulcers, burns, transplant sites, and others. The other segment here includes surgical procedures such as accidents related surgeries, and GI-related surgeries. The others segment held the largest market share in 2016 with a share of 28.00% for this segment. The Cardiovascular Disease (CVD) related segment is estimated to be the fastest-growing vertical with a CAGR of 6.0%.
CVD based surgeries are expected to increase due to its increasing disease burden. It has been estimated by the WHO that over 3/4th of the deaths due to CVD occur in developing countries. Thus, countries such as China, Japan are expected to be a potential region for this industry.
Additionally, diabetes-related complications are rising so the number of surgeries associated with them. Dressings such as alginates, hydrogels, antimicrobial agents, adhesive tapes, absorbents may be used in these surgeries. Therefore, the anticipated growth of the market can be attributed to an increase in diabetes based surgeries.
Pressure ulcers are also anticipated to grow at a lucrative rate. There are various types of ulcers that may require surgical procedures for the treatment or management of the disease. These ulcers include pressure ulcers, peptic ulcers, and venous leg ulcers.
The surgical dressing market is segmented into hospitals, specialty clinics, Ambulatory Surgery Centers (ASC), home healthcare, and other healthcare settings. The other healthcare settings include fire stations, police stations, and other emergency response teams.
The hospital segment held the largest market share in 2016 with a share of more than 50.0% for this segment. Hospitals require these products in large quantities as they are required for all surgeries and for all the secondary treatments as well. Hospitals generally issue an open tender offer for the procurement of these products.
The ASC segment is estimated to be the fastest-growing segment with a CAGR of around 6.0%
These centers are increasing in number in developed and developing countries and they reduce the pressure on hospitals and physician clinics. There are approximately 5,229 ASCs that are certified by Medicare.
Surgical dressing market, by region, 2016 (%)
North America dominated the global market for this vertical in 2016. This may be attributed to increasing lifestyle disorders, increasing awareness about organ transplantation, and a rise in the range and number of ASC.
Asia Pacific is anticipated to witness the fastest growth with a CAGR of 8.0%. This growth may be attributed to increasing medical tourism in this region. Additionally, the penetration of health insurance in this region is anticipated to increase over the forecast period. The number of ASC in this region is also increasing which is anticipated to drive the market for this region.
The key players in the market include Medline Industries, Inc. Smith & Nephew, Advancis Medical, Acelity, Medtronic, Alliqua Biomedical, Inc., 3M, Coloplast, ConvaTec, Inc., Mölnlycke Health Care AB. The key strategic initiatives include new product launches, mergers and acquisitions, and collaborations.
For instance, In September 2015, Advancis Medical announced a strategic agreement with DUKAL Corp. for the distribution and sale of their products. This strategic alliance is expected to expand the company’s product reach in the U.S. and Canada.
Report Attribute |
Details |
Market size value in 2020 |
USD 4,308.5 million |
Revenue forecast in 2025 |
USD 5.6 billion |
Growth Rate |
CAGR of 5.6% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; UK; Germany; Japan; China Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Medline Industries, Inc. Smith & Nephew; Advancis Medical; Acelity; Medtronic; Alliqua Biomedical, Inc.; 3M; Coloplast; ConvaTec, Inc.; Mölnlycke Health Care AB |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global surgical dressing market on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
Primary Dressing
Film dressing
Alginates
Soft silicone dressing
Composite dressing
Hydrogel
Hydrocolloid dressing
Foam
Secondary Dressing
Absorbents
Bandages
Muslin bandage rolls
Elastic bandage
Triangular bandage
Orthopedic bandage
Elastic plaster bandage
Others bandages
Adhesive tapes
Protectives
Others
Others
Application Outlook (Revenue, USD Million; 2014 - 2025)
Diabetes based surgeries
Cardiovascular diseases based surgeries
Ulcers
Burns
Transplant sites
Others
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
Hospital
Specialty Clinics
Home Healthcare
Ambulatory Surgical Centers (ASC)
Other Healthcare Settings
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
Latin America
Mexico
Brazil
MEA
South Africa
Saudi Arabia
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.